| TAH Drug Code | OCEPO |
|---|---|
| Indications | Hypertension, chronic heart failure. |
| Dosing | HTN initial 25mg TIDAC slow titrate up Maximum 450mg/day (Take one hour before meals ) CHF: initial dose of 6.25 or 12.5 mg TID in patients with normal or low blood pressure; maintence dose: -50mg TIDAC |
| Hepatic Impairment | Dose adjustment not necessary |
| Renal Impairment | Dose adjustment not necessary |
| Contraindications | Pregnancy |
| Adverse Effects | Dysgeusia, skin rash, cough |
| Pregnancy | Human Data Suggest Risk in 2nd and 3rd Trimesters |
| Lactation | Compatible |
| More Info | UpToDate |